daidzin has been researched along with Multiple Myeloma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, KS; Alahmadi, TA; Alharbi, SA; Chinnathambi, A; Jung, SH; Sethi, G; Yang, MH | 1 |
1 other study(ies) available for daidzin and Multiple Myeloma
Article | Year |
---|---|
Attenuation of STAT3 Signaling Cascade by Daidzin Can Enhance the Apoptotic Potential of Bortezomib against Multiple Myeloma.
Topics: Antineoplastic Agents; Apoptosis; Bortezomib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Humans; Isoflavones; Multiple Myeloma; Phosphorylation; Signal Transduction; STAT3 Transcription Factor | 2019 |